2021 ICD-10-CM Code R87.811
Vaginal high risk human papillomavirus (HPV) DNA test positive
Valid for Submission
R87.811 is a billable diagnosis code used to specify a medical diagnosis of vaginal high risk human papillomavirus (hpv) dna test positive. The code R87.811 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code R87.811 might also be used to specify conditions or terms like human papilloma virus deoxyribonucleic acid test positive, high risk on vaginal specimen or human papillomavirus deoxyribonucleic acid test positive.
The code R87.811 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.
According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.
| ICD-10: | R87.811 |
| Short Description: | Vaginal high risk HPV DNA test positive |
| Long Description: | Vaginal high risk human papillomavirus (HPV) DNA test positive |
Code Classification
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R87.811 are found in the index:
- - Abnormal, abnormality, abnormalities - See Also: Anomaly;
- - specimen
- - female genital organs (secretions) (smears) - R87.9
- - cytology - R87.69
- - vagina - R87.629
- - human papillomavirus (HPV) DNA test
- - high risk positive - R87.811
- - human papillomavirus (HPV) DNA test
- - vagina - R87.629
- - cytology - R87.69
- - female genital organs (secretions) (smears) - R87.9
- - specimen
- - Findings, abnormal, inconclusive, without diagnosis - See Also: Abnormal;
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Human papilloma virus deoxyribonucleic acid test positive, high risk on vaginal specimen
- Human papillomavirus deoxyribonucleic acid test positive
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code R87.811 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
Convert R87.811 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R87.811 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 795.15 - Vag hi risk HPV-DNA pos (Approximate Flag)
Information for Patients
HPV
Also called: Human papillomavirus
Human papillomaviruses (HPV) are a group of related viruses. They can cause warts on different parts of your body. There are more than 200 types. About 40 of those types affect the genitals. They are spread through sexual contact with an infected partner. Some of those can put you at risk for cancer.
There are two categories of sexually-transmitted HPV. Low-risk HPV can cause genital warts. High-risk HPV can cause various cancers:
- Cervical cancer
- Anal cancer
- Some types of oral and throat cancer
- Vulvar cancer
- Vaginal cancer
- Penile cancer
HPV infections are the most common sexually transmitted infections in the United States. Anyone who has ever been sexually active can get HPV, but you are more likely to get it if you have had many sex partners or have had sex with someone who has had many partners. Because it is so common, most people get HPV infections shortly after becoming sexually active for the first time.
Some people develop genital warts from HPV infection, but others have no symptoms. Most high-risk HPV infections go away within 1 to 2 years and do not cause cancer. Some HPV infections, however, can persist for many years. Those infections can lead to cell changes that, if not treated, may become cancerous.
In women, Pap tests can detect changes in the cervix that might lead to cancer. Pap tests, along with HPV tests, are used in cervical cancer screening.
Correct usage of latex condoms greatly reduces, but does not completely eliminate, the risk of catching or spreading HPV. The most reliable way to avoid infection is to not have anal, vaginal, or oral sex. Vaccines can protect against several types of HPV, including some that can cause cancer.
NIH: National Cancer Institute
- Cervical cancer -- screening and prevention (Medical Encyclopedia)
- Condom Fact Sheet in Brief (Centers for Disease Control and Prevention)
- HPV and Cancer (Centers for Disease Control and Prevention)
- HPV DNA test (Medical Encyclopedia)
- HPV vaccine (Medical Encyclopedia)
- Pap and HPV Testing - NIH (National Cancer Institute)
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)